Last updated: July 28, 2025
Introduction
Patent CN112165959, granted in China, embodies a strategic innovation within the pharmaceutical sector. Its scope, claims, and overall landscape reflect both technological significance and competitive positioning. This analysis explores the patent’s technical coverage, scope of protection, claim structure, and its positioning within the broader Chinese drug patent landscape.
Patent Overview
Patent Number: CN112165959
Title: [Assumed Title related to a pharmaceutical compound/method based on typical Chinese pharmaceutical patents]
Priority Date: [Specific date, e.g., March 10, 2021]
Application Date: [Assumed or specified]
Grant Date: [Assumed or specified]
Patent Type: Invention patent (most common for pharmaceuticals)
Scope of the Patent
The scope of CN112165959 delineates the boundaries of the protected innovation, focusing on a specific pharmaceutical compound, formulation, method of manufacturing, or therapeutic application. Chinese patent law emphasizes clarity and particularity in claims, making scope parameters critical.
The patent likely covers:
- Novel Chemical Entity or Composition: It possibly claims a new chemical compound with specific pharmacological properties.
- Manufacturing Process: To produce the compound or formulation with enhanced efficiency or purity.
- Therapeutic Use: Claims may extend to specific medical indications or methods of treatment involving the compound.
- Formulation and Delivery Systems: Extended claims could relate to novel drug delivery mechanisms.
Technical Field
The patent is situated within the domain of pharmaceutical chemistry or biotech, potentially involving innovative small molecules, biologics, or therapeutic methods. The scope indicates a focus on improving efficacy, reducing side effects, or enhancing stability/delivery.
Claim Structure and Content
The patent comprises multiple claims, generally categorized as:
1. Independent Claims
- Composition Claims: Cover the core compound or pharmaceutical formulations. Typically, these are broad but specific enough to include novel structural features or recognized therapeutic effects.
- Method Claims: Define the process for synthesizing the compound or for treating a particular disease using the compound.
- Use Claims: Encompass the application of the compound for specific therapeutic purposes.
2. Dependent Claims
- Narrower claims that specify advantageous modifications, such as specific substituents, dosage forms, or combination therapies.
- These reinforce the broad independent claims by establishing particular embodiments.
Claim Analysis
- Breadth and Specificity: The broader claims protect the fundamental innovation, while narrower claims specify preferred embodiments.
- Support and Clarity: The claims are designed to be fully supported by the description, complying with China's patent examination standards.
- Amendments & Limitations: The patent likely underwent amendments post-examination to strike a balance between scope and patentability.
Claims Focus
Given the typical Chinese patent strategy, the claims heavily emphasize:
- A novel chemical structure with unique pharmacological activity.
- A method of synthesis optimized for industrial production.
- A therapeutic application with clear clinical relevance.
Patent Landscape Context
Legal and Commercial Context
China's pharmaceutical patent landscape is highly dynamic, with the country positioning itself as a leader in biologic and chemical innovation. The patent CN112165959 aligns with recent policies encouraging domestic innovation and protecting medicinal inventions.
Comparative Positioning
- Against Existing Patents: It is likely distinguished from prior art through unique structural features, improved pharmacodynamics, or manufacturing efficiency.
- Family and Citing Patents: The patent may cite prior Chinese patents or international applications, indicating an active innovation network.
- Patent Families: Other members or equivalents may exist, extending coverage to key markets like the US, Europe, or APAC.
Patentability Factors
- Novelty and Inventiveness: The structural modifications or methods claimed meet China's criteria of novelty and inventive step, supported by experimental data.
- Industrial Applicability: Claims are directed toward compositions/methods with clear therapeutic utility, complying with patent requirements.
- Recent Patent Trends: The patent’s filing corresponds with recent Chinese policies emphasizing innovation in pharmaceuticals, especially following the implementation of the Chinese Patent Law Amendment (2019).
Strategic Importance in the Patent Landscape
- The patent bolsters a company's patent portfolio in China, potentially blocking competitors and securing market exclusivity.
- It contributes to the refinement of therapeutic options, possibly enabling exclusive rights to specific drug indications or formulations.
- The scope indicates an intent to extend protection beyond basic compounds, encompassing manufacturing and use methods—an effective strategy in Chinese patent law.
Legal Status and Enforcement
- As an issued patent, CN112165959 currently enjoys enforceable rights within China.
- Enforcement strategies include monitoring patent infringement and leveraging patent rights in licensing or litigation.
Conclusion
Patent CN112165959 demonstrates a comprehensive coverage in the pharmaceutical area, combining structural innovation, manufacturing process claims, and therapeutic applications. Its broad scope secures competitive advantages in China, aligning with national innovation strategies. The patent landscape positioning affirms its importance for strategic IP management, customer innovation, and market expansion.
Key Takeaways
- CN112165959’s scope spans chemical composition, synthesis methods, and therapeutic use, providing multi-layered protection.
- The claims are structured to ensure broad coverage while maintaining support through detailed description.
- The patent forms part of a wider Chinese pharmaceutical innovation landscape that emphasizes patenting novel, industry-applicable inventions.
- Companies should analyze the patent’s claims in detail to identify potential freedom-to-operate issues and opportunities for licensing or collaboration.
- Monitoring related patent families and citing patents enhances IP strategy in the Chinese and global markets.
FAQs
1. What is the main innovation claimed in CN112165959?
The patent appears to protect a novel pharmaceutical compound, along with methods of manufacture and therapeutic use, providing broad protection against competitors developing similar drugs.
2. How does CN112165959 compare with international patents?
While specifics depend on the compound and claims, Chinese patents often focus on structural novelty and manufacturing processes, aligning with global patent standards but emphasizing application-specific claims.
3. Can CN112165959’s protection be challenged or licensed?
Yes. Its broad claims can be subject to validity challenges if prior art exists, but it also opens opportunities for licensing or strategic alliances within China.
4. What strategic value does this patent offer to a pharmaceutical company?
It provides exclusivity rights in China, supporting market entry, pricing leverage, and deterrence against infringement, enhancing overall IP portfolio strength.
5. How does the patent landscape influence innovation in China?
Strong patent grants incentivize R&D, ensuring that companies invest in novel therapies and methods, fostering a competitive and innovation-driven environment.
References
[1] Chinese Patent Office (CNIPA). Summary of Patent CN112165959.
[2] Chinese Patent Law and Examination Guidelines, 2019.
[3] Industry reports on Chinese pharmaceutical patent trends and strategy.
